HONcode certificate: respect of the 8 HONcode principles by the health website

| | | | | | |

Certificate of compliance with the Code of Conduct HONcode

The health Website
RELIS - Regionalt legemiddelinformasjonssenter
is in compliance with the HONcode

Title of the site: RELIS - Regionalt legemiddelinformasjonssenter
Web address: http://www.relis.no/
HONcode PIN number : HONConduct885976
Date of initial review: 04 Jun 2000
Validity of certificate 12 Feb 2013 - Feb 2015
Date of last visit 12 Feb 2013
Show the HONcode seal on this site

This certificate confirms the revision of the site by the HONcode Team at the above date.
It respects and pledges to honor the 8 principles of the HON Code of Conduct (HONcode).

* 1. Authoritative 2. Complementarity 3. Privacy 4. Attribution 5. Justifiability 6. Transparency
7. Financial disclosure 8. Advertising policy

Speed access of ethical health information online is critical.

Help us in our mission:

Do you think the site is not respecting the HONcode?

The Health on the Net (HON) certificate serves as a guarantee that this website, at the date of its certification, complies with and pledges to honor the 8 principles of the HON Code of Conduct as drawn up by the HON foundation.

The responsible of the certified site commits to keep the site in compliance with the HON code principles for the duration of the certification.

Although measures such as a complaint mechanism, the periodical review and the automatic surveillance mechanisms are put in place to guarantee the compliance of the certified website with the ethical principles of HON as much as possible, incidental inaccuracies cannot be completely excluded. In no event the HON foundation and/or its partner(s) can be held liable for any damages resulting from the use or inability to use HON certified websites nor can the HON foundation and/or its partner(s) be held liable for the content of these certified websites, including, but not limited to the information of third-parties or hyperlinks accessible via HON certified websites.

The certified website is responsible for the content of its website, unless otherwise provided by law.

>>

You will find below the elements identified by the HONcode team at a precise date to justify the respect of the 8 ethical principles.

The content of this certificate has been collected and written by the Health On the Net Foundation (HON) and should not be used without previous permission granted by HON. A request for permission can be sent to: HON.

1. Information must be authoritative

2. Presentation of the site
Mission:

Hva er RELIS?
Produsentuavhengig legemiddelinformasjon
RELIS – regionale legemiddelinformasjonssentre – er etablert for å bidra til rasjonell og riktig legemiddelbruk gjennom produsentuavhengig legemiddelinformasjon til helsepersonell. Faglig forsvarlig og riktig bruk av legemidler er et sentralt tema i norsk legemiddelpolitikk.

Knyttet til helseregion
RELIS begynte virksomheten ved to sentre i 1995, og har siden 2001 vært etablert ved universitetssykehus i samtlige helseregioner. Alle sentrene er knyttet til de klinisk farmakologiske fagmiljøene ved universite... (25 Jan 2013) -

Audience:

Purpose of the website

This principle is not applicable for this site

3. Confidentiality

Alle sider unntatt databasen
RELIS samler ikke inn informasjon som kan knyttes til person, bare informasjon som serveren loggfører ved besøk for vår interne statistikk. Vi benytter Google Analytics for å registrere statistikk fra disse besøkene som brukes til å se på bruksmønster for å forbedre våre websider. For mer informasjon om personvern og Google Analytics se: http://www.google.com/intl/en_uk/analytics/privacyoverview.html

RELIS finansieres ved tilskudd fra Helse- og omsorgsdep... (12 Feb 2013) -

4. Information must be documented: Referenced and dated

Only data for one sample are displayed among those selected.

Kilde: Brenne, I. Behandling av gastroparese. Utposten 2012;7: 46-7

Referanser:

Dansk lægehåndbok. Diabetes, gastrointestinale kompl. http://www.laegehaandbogen.dk/ (Sist oppdatert 28. mars 2012).
Ajumobi AB, Griffin RA. Diabetic Gastroparesis: Evaluation and Management. Hospital Physician 2008; pp.27-35
Statens legemiddelverk. Cisaprid og domperidon - risiko for alvorlige hjertebivirkninger.http://www.legemiddelverket.no/ (Sist gjennomgått: 24. november 2011)
Statens legemiddelverk. ... (25 Jan 2013) -

Publisert 02.02.10
(25 Jan 2013) -

5. Justification of claims

This principle is not applicable for this site

6. User support and adequation

Kontakt oss
(25 Jan 2013) -

7. Disclosure of funding sources

Offentlig finansiering
RELIS finansieres ved tilskudd fra Helse- og omsorgsdepartementet (HOD). Tilskuddsforvalter er Statens legemiddelverk. Virksomheten styres gjennom årlige oppdragsbrev.
(25 Jan 2013) -

8. Advertising policy

Vi har ingen reklame på våre websider og samler følgelig heller ikke inn statistikk for bruk mot reklametilbydere eller reklameplassering.
(12 Feb 2013) -

You have your own website ?

Automatic verification of the certification status of health/medical websites.